Page 6 - Topline News Today

- U.S. Clinical Sites Screening Treatment-Experienced Participants with Wet AMD - - ODYSSEY Topline Results Expected in Q3 2024 - ALPHARETTA, Ga., June 01, 2023 -- Clearside Biomedical,... | June 1, 2023

Topline Results from Cohort 6 in the Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria May 31, 2023 ... | May 31, 2023

Parsippany - Ferring Pharmaceuticals announced that its clinical development partner, Seikagaku Corporation , achieved positive topline results for its registrational Phase 3 clinical trial of... | May 29, 2023

More about what that would actually mean?— actually mean? well, at the moment. — actually mean? well, at the moment, there _ actually mean? well, at the moment, there has - actually mean? well, at the moment, there has been i actually mean? well, at the moment, there has been a l moment, there has been a different sort of topline tossed around. i had fiscal year 2022, with the addition of inflation, but basically, both parties are trying to find an area where they can land, democrats are try...

The idea of the biggest issue is the topline spending numbers. the fact were hearing more complaining about issues other than that suggests we may have made some progress on the biggest issue and turning the dials to see where we can land on a compromise to get the votes needed to pass the house. >> complicated indeed. brendan, punch bowl news reports a deal would need to be reached today or tomorrow in order for the house floor to be able to deal with that by wednesday. the day before this supp...

Rain Oncology Inc. announced its topline pivotal Phase 3 MANTRA data. The trial, evaluating the efficacy, safety, and tolerability of milademetan in patients with dedifferentiated liposarcoma , did... | May 23, 2023

- Conference call and webcast to be held at 5:00 pm EDT -  SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. today reported topline results from the MOVE-FA... | May 23, 2023

REGULATED INFORMATION ALLOB Phase IIb topline results foreseen in July/August 2023Ongoing discussions for key partnerships with lead clinical assets Mont-Saint-Guibert, Belgium, May 22nd,... | May 22, 2023

The world needs better vaccines. Were striving to create them. IVX-A12 Phase 1 Topline Interim Data |... | May 22, 2023

APHENITY Topline Results Matthew Klein, M.D. CEO May, 2023 ... | May 17, 2023